Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : 524816 | NSE Symbol : NATCOPHARM | ISIN : INE987B01026 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

(24-Jul-25 15:34) Natco Pharma's API unit in Mekaguda clears USFDA inspection
(24-Jul-25 15:09) Natco Pharma receives USFDA EIR for Hyderabad API facility
(18-Jul-25 13:00) Natco Pharma Ltd spurts 0.35%, gains for five straight sessions
(20-Jun-25 09:54) Natco Pharma receives seven observations from USFDA Following Inspection at Kothur Facility
(14-Jun-25 13:45) NATCO Pharma's Hyderabad-based plant gets 'one' Form 483 observation post US FDA audit
(13-Jun-25 16:27) Natco Pharma's Mekaguda API unit completes USFDA inspection
(11-Jun-25 13:05) Natco Pharma Ltd gains for third consecutive session
(29-May-25 15:50) Natco Pharma gains after Q4 PAT rises 5% YoY to Rs 407 cr
(28-May-25 17:15) Natco Pharma consolidated net profit rises 5.25% in the March 2025 quarter
(13-May-25 10:19) Natco Pharma to conduct board meeting

1 2 3 4 5 6 7 8 9 10

Natco Pharma Ltd